Stellanova Therapeutics

United States
Awendaw, South Carolina, United States, TX 77021

Company profile

Stellanova Therapeutics company profile

Stellanova Therapeutics is a private, development-stage biotechnology company in Houston Texas advancing therapies targeting the tumor microenvironment to treat cancers resistant to current therapies. The company’s platform centers on a drug pipeline targeting cancer-associated fibroblasts that spur tumors, an approach which has, to date, shown unprecedented anti-tumor activity in multiple resistant cancer models

Business identity

Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2019-01-01, Year

Headquarters

Postal code
TX 77021
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
1
Total equity funding
$15.5M
Last funding
Series A / $15.5M / 2021-06-03
Last equity funding
Series A / $15.5M
Investors
1
Lead investors
1
Founders
2

Founders and investors

Founders

Ronald A. DePinhoRosa F. Hwang

Lead investors

Sporos Bioventures

Investors

Sporos Bioventures